- Home
- UBSI vs GRFS Comparison
UBSI vs GRFS Comparison
Compare UBSI & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UBSI | GRFS |
|---|---|---|
| Founded | 1982 | 1940 |
| Country | United States | Spain |
| Employees | N/A | 25247 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 4.9B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | UBSI | GRFS |
|---|---|---|
| Price | $47.91 | $7.64 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $43.17 | $10.15 |
| AVG Volume (30 Days) | ★ 1.0M | 647.2K |
| Earning Date | 04-23-2026 | 07-28-2022 |
| Dividend Yield | ★ 3.51% | 1.80% |
| EPS Growth | ★ 18.91 | N/A |
| EPS | ★ 0.89 | N/A |
| Revenue | ★ $311,957,000.00 | N/A |
| Revenue This Year | $10.13 | $4.49 |
| Revenue Next Year | $5.36 | $6.42 |
| P/E Ratio | $53.21 | ★ $18.67 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $34.10 | $6.96 |
| 52 Week High | $48.22 | $11.14 |
Technical Indicators
Market Signals| Indicator | UBSI | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 63.38 | 55.96 |
| Support Level | $43.29 | $7.64 |
| Resistance Level | $48.22 | $7.73 |
| Average True Range (ATR) | 0.80 | 0.16 |
| MACD | 0.02 | 0.07 |
| Stochastic Oscillator | 87.93 | 68.62 |
Price Performance
Historical ComparisonAbout UBSI United Bankshares Inc.
United Bankshares Inc is a financial holding company that provides banking services. The company operates in one segment: Community banking, which offers a full range-of-products and services through various delivery channels. Included among the banking products and services offered are the acceptance of deposits in checking, savings, time, and money market accounts; the making and servicing of personal, credit card, commercial, and floor plan loans; and the making of construction and real estate loans, as well as the origination and sale of residential mortgages in the secondary market. Also offered are trust and brokerage services, safe deposit boxes, and wire transfers.
About GRFS Grifols S.A.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.